1. Home
  2. CORT vs HII Comparison

CORT vs HII Comparison

Compare CORT & HII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$121.38

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Huntington Ingalls Industries Inc.

HII

Huntington Ingalls Industries Inc.

N/A

Current Price

$264.90

Market Cap

10.1B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
HII
Founded
1998
1886
Country
United States
United States
Employees
N/A
44000
Industry
Biotechnology: Pharmaceutical Preparations
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
10.1B
IPO Year
2001
2010

Fundamental Metrics

Financial Performance
Metric
CORT
HII
Price
$121.38
$264.90
Analyst Decision
Buy
Buy
Analyst Count
5
12
Target Price
$141.00
★ $363.00
AVG Volume (30 Days)
★ 872.9K
457.9K
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
★ 2.08%
EPS Growth
N/A
★ 10.24
EPS
0.09
★ 9.06
Revenue
$761,407,000.00
★ $12,484,000,000.00
Revenue This Year
$50.53
$7.06
Revenue Next Year
$48.75
$6.38
P/E Ratio
$1,317.11
★ $29.25
Revenue Growth
★ 12.79
8.23
52 Week Low
$28.66
$256.79
52 Week High
$126.38
$460.00

Technical Indicators

Market Signals
Indicator
CORT
HII
Relative Strength Index (RSI) 59.16 40.91
Support Level $108.33 $260.20
Resistance Level $123.01 $275.98
Average True Range (ATR) 5.11 6.62
MACD 0.39 0.80
Stochastic Oscillator 83.38 38.93

Price Performance

Historical Comparison
CORT
HII

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About HII Huntington Ingalls Industries Inc.

Huntington Ingalls Industries is the largest independent military shipbuilder in the US, spun out from Northrop Grumman in 2011. It operates three segments, two of which are storied shipyards: Ingalls produces non-nuclear-powered ships, including amphibious landing ships and Arleigh Burke-class destroyers, while Newport News produces nuclear-powered ships as the only producer of Gerald Ford-class aircraft carriers and a major subcontractor on Virginia- and Columbia-class nuclear submarines. HII shares production of destroyers and nuclear submarines with General Dynamics' Bath Iron Works and Electric Boat shipyards, respectively. The company's mission technologies segment produces uncrewed sea vessels and provides a range of IT and other services to US government agencies.

Share on Social Networks: